SECTION 2. HAZARDS IDENTIFICATION

Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
Skin corrosion(Category 1B), H314
Serious eye damage(Category 1), H318
Acute aquatic toxicity(Category 2), H401
Chronic aquatic toxicity(Category 3), H412
GHS Label elements, including precautionary statements
Pictogram

Signal word
Danger
Hazard statement(s)
H314
Causes severe skin burns and eye damage.
H401
Toxic to aquatic life.
H412
Harmful to aquatic life with long lasting effects.
Precautionary statement(s)
P260
Do not breathe dust or mist.
P264
Wash skin thoroughly after handling.
P273
Avoid release to the environment.
P280
Wear protective gloves/ protective clothing/ eye protection/ face protection.
P301 + P330 + P331
IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P303 + P361 + P353
IF ON SKIN (or hair): Take off immediately all contaminated clothing.
Rinse skin with water/shower.
P304 + P340 + P310
IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/doctor.
P305 + P351 + P338 + P310
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor.
P363
Wash contaminated clothing before reuse.
P405
Store locked up.
P501
Dispose of contents/ container to an approved waste disposal plant.
Hazards not otherwise classified (HNOC) or not covered by GHS-none

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

Substances
Formula: Cl4Sn 5H2O
Molecular weight: 350.60 g/mol
CAS-No.: 10026-06-9

SECTION 4. FIRST AID MEASURES

Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
Continue rinsing eyes during transport to hospital.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person.
Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2) and/or in section 11
Indication of any immediate medical attention and special treatment needed
No data available

SECTION 5. FIREFIGHTING MEASURES

Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
No data available
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

SECTION 6. ACCIDENTAL RELEASE MEASURES

Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing Vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7. HANDLING AND STORAGE

Precautions for safe handling
Avoid formation of dust and aerosols.
Further processing of solid materials may result in the formation of combustible
dusts. The potential for combustible dust formation should be taken into consideration before additional processing occurs.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.
Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place.
Moisture sensitive.
Specific end use(s)
Apart from the uses mentioned in section 1 no other specific uses are stipulated

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal
technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

Information on basic physical and chemical properties
Appearance
Form: Solid form
Odor
No data available
Odor Threshold
No data available
pH
No data available
Melting point/freezing point
No data available
Initial boiling point and boiling range
No data available
Flash point
N/A
Evaporation rate
No data available
Flammability (solid, gas)
No data available
Upper/lower flammability or explosive limits
No data available
Vapor pressure
No data available
Vapor density
No data available
Relative density
No data available
Water solubility
No data available
Partition coefficient: n-octanol/water
No data available
Auto-ignition temperature
No data available
Decomposition temperature
No data available
Viscosity
No data available
Explosive properties
No data available
Oxidizing properties
No data available
Other safety information
No data available

SECTION 10. STABILITY AND REACTIVITY

Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Strong acids
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions.-Hydrogen chloride gas, Tin/tin oxides
Other decomposition products-No data available
In the event of fire: see section 5

SECTION 11. TOXICOLOGICAL INFORMATION

Information on toxicological effects
Acute toxicity
No data available
Inhalation: No data available
Dermal: No data available
LD50 Intraperitoneal-Rat-120 mg/kg
LD50 Intravenous-Mouse-32 mg/kg
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
Human
lymphocyte
Sister chromatid exchange
Human
lymphocyte
Cytogenetic analysis
Carcinogenicity
IARC:
No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
NTP:
No component of this product present at levels greater than or equal to 0.1% is identified as a
known or anticipated carcinogen by NTP.
OSHA:
No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.
Reproductive toxicity
No data available
No data available
Specific target organ toxicity -single exposure
No data available
Specific target organ toxicity -repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: XP8870000
Inorganic tin salts are poorly absorbed into the body. When parenterally administered tin salts are highly toxic. Tin oxide inhaled as a dust or fume leads to a benign pneumoconiosis with no sign of interference with pulmonary function.
Deposited dust appears nodular with the particles being mostly extracelluar. No necrosis, foreign-
body giant-cell reaction, or collagen formation has been seen. Tin salts that have gained access to the blood stream are highly toxic and produce neurologic damage and paralysis. With most common tin salts, the toxicity profile is complicated by hydrolysis in body fluids producing unphysiologic pH values. The reported symptoms of hyperemia, vascular changes with bleeding in the central nervous system, liver, heart, and other organs may be due to tin itself or to the unphysiological pH changes.
Ingestion produces vomiting due to the gastric irritation from the activity and astringency of tin compounds. Injection of inorganic tin salts produces diarrhea, muscle paralysis, and twitching., Material is extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and skin., spasm, inflammation and edema of the larynx, spasm, inflammation and edema of the bronchi, pneumonitis, pulmonary edema, burning sensation, Cough, wheezing, laryngitis,
Shortness of breath, Headache, Nausea, Vomiting, To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.

SECTION 12. ECOLOGICAL INFORMATION

Toxicity
Toxicity to fish
LC50-Danio rerio (zebra fish)-> 1.000 mg/l-96 h
(OECD Test Guideline 203)
Remarks: anhydrous
Toxicity to daphnia and other aquatic invertebrates
EC50-Daphnia magna (Water flea)-21.5 mg/l-48 h
Remarks: anhydrous
Toxicity to algae
IC50-Scenedesmus quadricauda (Green algae)-> 50 mg/l-4 h
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
An environmental hazard cannot be excluded in the event of unprofessional handling or disposal.
Toxic to aquatic life.
No data available

SECTION 13. DISPOSAL CONSIDERATIONS

Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contact a licensed professional waste disposal service to dispose of this material.
Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14. TRANSPORT INFORMATION

DOT (US)
UN number: 2440
Class: 8
Packing group: III
Proper shipping name: Stannic chloride pentahydrate
Reportable Quantity(RQ):
Poison Inhalation Hazard: No
IMDG
UN number: 2440
Class: 8
Packing group: III
EMS-No: F-A, S-B
Proper shipping name: STANNIC CHLORIDE PENTAHYDRATE
IATA
UN number: 2440
Class: 8
Packing group: III
Proper shipping name: Stannic chloride pentahydrate

SECTION 15. REGULATORY INFORMATION

SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
Acute Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
Tetrachlorostannane pentahydrate
CAS-No.
10026-06-9
Revision Date
2007-03-01
Tetrachlorostannane pentahydrate
CAS-No.
10026-06-9
Revision Date
2007-03-01
New Jersey Right To Know Components
Tetrachlorostannane pentahydrate
CAS-No.
10026-06-9
Revision Date
2007-03-01
California Prop. 65 Components
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other reproductive harm.